Biocare Medical Acquires Empire Genomics
The company believes its existing technology portfolio will be complemented by Empire's molecular probe business, better aiding cancer research and diagnostics.
SeekIn Nabs CE Mark for Cancer Assay
The biotech firm said its inexpensive and noninvasive test improves on existing screening methods and could help expand access to early cancer detection.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Neurodegenerative Disease Testing Firm CND Life Sciences Closes $2.4M Seed Financing Round
The financing will go toward the expansion of the company's laboratory operations and acceleration of the sales and marketing efforts of its Syn-One Test.
Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China
The deal to create a comprehensive genomic profiling test for Illumina's NextSeq 550Dx comes months after the instrument received regulatory approval in China.